Skip to content
Search

Latest Stories

Experts hit out at rising cost of UK drug prices

By Nadeem Badshah

MIGRANTS and visitors to the UK are faced with huge bills due to the cost of life-saving medicine and rising NHS immigration fees, a charity has warned.

A study of 50 countries found the US has the most expensive medication in the world, with the UK in 21st place and India in 46th.


Experts believe Britain can slash the price of medicine for patients by buying more products from generic companies over big brands.

Branded and generic medicine in the UK costs around five per cent more than the global average, compared to it being 73 per cent cheaper in India.

People visiting the UK from abroad and immigrants have to pay for NHS treatment, which can lead to them having a bill of hundreds of pounds for drugs.

Nazek Ramadan, director of the Migrant Voice charity, told Eastern Eye: “When medication is expensive, this is a problem for every person in that society – but in the UK, it’s often migrants who feel the costs the most.

“There’s the rising NHS surcharge – currently £400 per person per year – which every non-EU migrant in the UK has to pay, and upfront charges for healthcare for visitors and migrants considered ineligible for treatment.

“For many, the costs are simply unaffordable and they become stuck in cycles of debt. Others can’t afford vital treatment so avoid having it. It’s a dysfunctional system that devalues human lives.”

The research looked at the average price of medicine for conditions including erectile dysfunction, anxiety disorders, cardiovascular disease and high cholesterol, asthma, bacterial infection and diabetes.

Patients in the UK pay 75 per cent more for a drug to treat cardiovascular disease and high cholesterol, compared to the global average; they also pay 57 per cent more for medicines for epilepsy and anxiety.

Health experts said buying more generic brands can lead to lower prices for patients, but cautioned safety tests on pills in the UK can also lead to higher costs.

Daniel Kolb, managing director of digital healthcare provider Medbelle which carried out the study, said when it comes to prices in the UK compared to India, the research shows how laws and the cost towards patented branded drugs and generic compounds impacts how much money is spent on medicine.

He told Eastern Eye: “People in the UK for instance have, in general, better access to branded drugs than people from India, likely due to purchasing power and patent rights.

“So while the UK appears to spend more on medicine than India, the reality is people from India buy more generic compounds than branded ones, hence the lower overall costs.

“In India, some of the branded drugs – like the incredibly expensive arthritis medicine Humira (Adalimumab) – are not available, at least to the general public.

“Not only can the UK afford branded drugs, but there is also some reason to believe that original patented compounds are considered more ‘trustworthy’ by consumers, which might be one explanation.

“If the UK wants to cut down medicine costs, investing in more generic brands over branded ones is one way to save money.”

Professor Mahendra Patel, an associate member of the British Association of Physicians of Indian Origin, believes the UK has one of the highest safety quality assurances in the world.

He added: “Our medicines are regulated by the Medicines and Healthcare products Regulatory Agency, so the patient knows the standard and quality.

“You have the full assurance of that, it gives the patient peace of mind. In other countries, it may not be regulated to that level.

“I’m not saying it justifies the cost, but there is a high level of scrutiny and assurance before drugs comes out on the market.

“While it could be cheaper in other non-Western countries, do they know who is supplying it, the storage conditions, ingredients? Safety comes first.”

Political rivals row over drug prices

A ROW has erupted between the Conservatives and Labour over potential NHS drug price increases.

It emerged that George Hollingbery, then a UK trade minister, held a meeting with US drugs giant Eli Lilly last year to discuss “future trade” deals post-Brexit.

The revelation backs Labour’s claim the Tories may selloff the NHS to Donald Trump and US pharmaceutical firms.

Jeremy Corbyn has warned NHS drug prices would rise in a deal signed with the US president.

The Labour leader revealed a 451-page dossier last week on initial talks which he argued proved the health service was “for sale”.

Barry Gardiner, shadow secretary of state for international trade, said: “A trade deal with Trump could drain £500 million a week from the NHS to US corporations. This is more evidence the NHS is on the table.”

Prime minister Boris Johnson said the claims were “nonsense” and the NHS would not be part of formal talks. The Tory manifesto states neither the price paid for drugs or NHS services will be “on the table”.

More For You

Man found guilty of rape and murder of Irish backpacker in India

McLaughlin, 28, from County Donegal, was found dead in a field in Goa in March 2017. (Photo credit: Twitter)

Man found guilty of rape and murder of Irish backpacker in India

A COURT in India has found Vikat Bhagat guilty of the rape and murder of Irish backpacker Danielle McLaughlin.

McLaughlin, 28, from County Donegal, was found dead in a field in Goa in March 2017.

Keep ReadingShow less
Alderman Alastair King

King, who serves as the global ambassador for the City of London, will be in Mumbai to discuss trade and investment under his mayoral theme, 'Growth Unleashed.'

Lord Mayor of London to visit India for trade talks

THE LORD MAYOR of London, Alderman Alastair King, is set to visit India for a week starting Saturday, aiming to promote free trade and capital flows between the two countries.

King, who serves as the global ambassador for the City of London, will be in Mumbai to discuss trade and investment under his mayoral theme, “Growth Unleashed.”

Keep ReadingShow less
trump-modi-washington-getty

The meeting came hours after Trump criticised India’s business environment and announced plans for reciprocal tariffs on countries that impose duties on US imports. (Photo: Getty Images)

Modi and Trump agree to resolve trade disputes, discuss tariff concerns

INDIA and the US have agreed to begin negotiations aimed at resolving trade and tariff disputes, following talks between Indian prime minister Narendra Modi and US president Donald Trump in Washington.

India has committed to increasing purchases of US oil, gas, and defence equipment, while both sides pledged to address trade barriers.

Keep ReadingShow less
Pablo-Escobar-merchandise-Getty

Escobar, killed by security forces in 1993, remains a figure of global interest, with his image appearing on souvenirs like T-shirts, mugs, and keychains. (Photo: Getty Images)

Colombia considers ban on Pablo Escobar merchandise

COLOMBIA’s Congress is considering a bill that would ban the sale of merchandise featuring drug lord Pablo Escobar and other convicted criminals.

The proposed law aims to curb the glorification of Escobar, who was responsible for thousands of deaths during his time leading the Medellín cartel, reported BBC.

Keep ReadingShow less
Assisted dying bill: Judge approval scrapped for expert panel safeguard

Polls show most Britons back assisted dying, with supporters calling for the law to reflect public opinion.

Assisted dying bill: Judge approval scrapped for expert panel safeguard

Eastern Eye

THE proposed new assisted dying law for terminally ill people will be amended to remove the requirement that a high court judge sign off on each case, Labour MP Kim Leadbeater said on Tuesday (11).

Opponents of assisted dying said the change would weaken the safeguards around protecting vulnerable people from being coerced or pressured into taking their own lives.

Keep ReadingShow less